Resultats de la cerca - David V. Erbe

  • Mostrar 1 - 8 resultats de 8
Refinar resultats
  1. 1
    Reduction in urinary oxalate excretion in mouse models of Primary Hyperoxaluria by RNA interference inhibition of liver lactate dehydrogenase activity

    Reduction in urinary oxalate excretion in mouse models of Primary Hyperoxaluria by RNA interference inhibition of liver lactate dehydrogenase activity per Kyle D. Wood, Ross P. Holmes, David V. Erbe, Abigail Liebow, Sonia Fargue, John Knight

    Publicat 2019
    Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:
  2. 2
    An Investigational RNAi Therapeutic Targeting Glycolate Oxidase Reduces Oxalate Production in Models of Primary Hyperoxaluria

    An Investigational RNAi Therapeutic Targeting Glycolate Oxidase Reduces Oxalate Production in Models of Primary Hyperoxaluria per Abigail Liebow, Xingsheng Li, Timothy Racie, Julia Hettinger, Brian R. Bettencourt, Nader Najafian, Patrick Haslett, Kevin Fitzgerald, Ross P. Holmes, David V. Erbe, William Querbes, John Knight

    Publicat 2016
    Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:
  3. 3
    Neurofilament Light Chain as a Biomarker of Hereditary Transthyretin-Mediated Amyloidosis

    Neurofilament Light Chain as a Biomarker of Hereditary Transthyretin-Mediated Amyloidosis per Simina Ticau, Gautham Sridharan, Shira Tsour, William Cantley, Amy Chan, Jason A. Gilbert, David V. Erbe, Emre Aldinc, Mary M. Reilly, David Adams, Michael Polydefkis, Kevin Fitzgerald, Akshay Vaishnaw, Paul Nioi

    Publicat 2020
    Obtenir text complet Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:
  4. 4
    A zymogen-like factor Xa variant corrects the coagulation defect in hemophilia

    A zymogen-like factor Xa variant corrects the coagulation defect in hemophilia per Lacramioara Ivanciu, Raffaella Toso, Paris Margaritis, Giulia Pavani, Haein Kim, Alexander Schlachterman, Jianhua Liu, Valérie Clerin, Debra D. Pittman, Rosalind Rose-Miranda, Kathleen Shields, David V. Erbe, James F. Tobin, Valder R. Arruda, Rodney M. Camire

    Publicat 2011
    Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:
  5. 5
    Crystal Structure of an HSA/FcRn Complex Reveals Recycling by Competitive Mimicry of HSA Ligands at a pH-Dependent Hydrophobic Interface

    Crystal Structure of an HSA/FcRn Complex Reveals Recycling by Competitive Mimicry of HSA Ligands at a pH-Dependent Hydrophobic Interface per Michael M. Schmidt, Sharon A. Townson, Amy Andreucci, Bracken M. King, Emily B. Schirmer, Alec Murillo, Christian Dombrowski, Alison W. Tisdale, Patricia Lowden, Allyson Masci, Joseph Kovalchin, David V. Erbe, K. Dane Wittrup, Eric S. Furfine, Thomas M. Barnes

    Publicat 2013
    Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:
  6. 6
    Phase 1/2 Study of Lumasiran for Treatment of Primary Hyperoxaluria Type 1

    Phase 1/2 Study of Lumasiran for Treatment of Primary Hyperoxaluria Type 1 per Yaacov Frishberg, Georges Deschênes, Jaap W. Groothoff, Sally‐Anne Hulton, Daniella Magen, Jérôme Harambat, William G. van’t Hoff, Ulrike Lorch, Dawn S. Milliner, John C. Lieske, Patrick Haslett, Pushkal Garg, Akshay Vaishnaw, Sandeep Talamudupula, Jiandong Lu, Bahru Habtemariam, David V. Erbe, Tracy L. McGregor, Pierre Cochat

    Publicat 2021
    Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:
  7. 7
    Characterising a healthy adult with a rare HAO1 knockout to support a therapeutic strategy for primary hyperoxaluria

    Characterising a healthy adult with a rare HAO1 knockout to support a therapeutic strategy for primary hyperoxaluria per Tracy L. McGregor, Karen A. Hunt, Elaine Yee, Dan Mason, Paul Nioi, Simina Ticau, Marissa Pelosi, Perry R Loken, Sarah Finer, Debbie A. Lawlor, Eric B. Fauman, Qin Qin Huang, Chris Griffiths, Daniel G. MacArthur, Richard C. Trembath, Devin Oglesbee, John C. Lieske, David V. Erbe, John Wright, David A. van Heel

    Publicat 2020
    Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:
  8. 8
    Scaffold-based discovery of indeglitazar, a PPAR pan-active anti-diabetic agent

    Scaffold-based discovery of indeglitazar, a PPAR pan-active anti-diabetic agent per Dean R. Artis, Jack J. Lin, Chao Zhang, Weiru Wang, Upasana Mehra, Mylène Perreault, David V. Erbe, Heike I. Krupka, B.P. England, J. Malcolm O. Arnold, A.N. Plotnikov, Adhirai Marimuthu, Hoa Nguyen, Sarah Will, Maxime Signaevsky, John G. Kral, John Cantwell, Calvin Settachatgull, Douglas S. Yan, Daniel W. Fong, Angela J. Oh, Shenghua Shi, Patrick Womack, Benjamin E. Powell, Gaston Habets, Brian L. West, Kam Y. J. Zhang, Michael V. Milburn, George P. Vlasuk, K. Peter Hirth, K. B. Nolop, Gideon Bollag, Prabha N. Ibrahim, James F. Tobin

    Publicat 2008
    Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:

Eines de cerca: